Annual report pursuant to Section 13 and 15(d)

Intangible Assets, Net - ProstaGene (Details)

v3.23.2
Intangible Assets, Net - ProstaGene (Details) - USD ($)
shares in Millions, $ in Millions
1 Months Ended 3 Months Ended
May 19, 2022
Mar. 31, 2021
Feb. 28, 2021
Intangible Assets, net      
Shares subject to arbitration   3.1  
Intangible asset impairment charge     $ 10.0
Impairment charge, gross     12.2
Impairment charge, reversal of accumulated amortization     $ 2.2
Non cash charge $ 0.8